RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.180
+0.030 (2.61%)
Oct 24, 2025, 4:00 PM EDT - Market closed
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $43.24 million as of October 27, 2025. Its market cap has increased by 82.10% in one year.
Market Cap
43.24M
Enterprise Value
31.19M
1-Year Change
82.10%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $43.24M, a decrease of -37.00%. That is a compound annual growth rate of -10.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 43.24M | 39.66% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |